在线问诊

A Gene-Based Approach to Epilepsy Therapy

Pauline Anderson

PHILADELPHIA — The next phase of personalized medicine in epilepsy may be therapy that is tested and targeted to the specific genetic mutation causing an individual's seizure disorder.

A new genetic research company is the first to pair expertise in rare disease genomics with advanced analytics to provide healthcare professionals with an extensive and highly personalized evaluation on individual epilepsy patients.

Medscape Medical News spoke to Pairnomix CEO Matthew Fox during the American Epilepsy Society (AES) 69th Annual Meeting to discuss this new initiative.